Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nuo Therapeutics, Inc.AURX · Entity 7149 | Director | June 29, 2026 | July 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nuo Therapeutics, Inc.
Report date June 29, 2026 · Filed July 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 173,050 |
Ending reported balance
After 2026-06-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-30 · Exercise / conversion · Acquired 40,000 · Balance 212,654 Row 2 · 2026-06-30 · Tax withholding · Disposed 39,604 · Balance 173,050 F1: Represents a net exercise of outstanding stock options. The reporting person received 396 shares of common stock on the net exercise of option to purchase 40,000 shares of common stock. The issuer withheld 39,604 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.01. |
| Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2026-06-30 | Direct | 0 |
Reported balance
After 2026-06-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-30 · Exercise / conversion · Disposed 40,000 · Balance 0 F2: 15,000 options exercisable on 07/01/2016 and 25,000 options exercisable on 01/01/2017. |
| Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2036-06-29 | Direct | 30,000 |
Reported balance
After 2026-06-29 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-29 · Grant · Acquired 30,000 · Balance 30,000 F3: The options fully vest as of June 30, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a net exercise of outstanding stock options. The reporting person received 396 shares of common stock on the net exercise of option to purchase 40,000 shares of common stock. The issuer withheld 39,604 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.01.
F2: 15,000 options exercisable on 07/01/2016 and 25,000 options exercisable on 01/01/2017.
F3: The options fully vest as of June 30, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2026 Filed Jul 3, 2026 00:59 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionOption to purchase common stock · Derivative | 40,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001437749-26-022662 · rdgdoc.xml · derivative · entry 3 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2026-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 15,000 options exercisable on 07/01/2016 and 25,000 options exercisable on 01/01/2017. Read SEC document |
| June 30, 2026 Filed Jul 3, 2026 00:59 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Tax withholdingCommon Stock | 39,604 | $1.01 | $40,000.04 |
DisclosureSEC source: 0001437749-26-022662 · rdgdoc.xml · nonDerivative · entry 2 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,050 F1 · kind: Represents a net exercise of outstanding stock options. The reporting person received 396 shares of common stock on the net exercise of option to purchase 40,000 shares of common stock. The issuer withheld 39,604 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.01. Read SEC document |
| June 30, 2026 Filed Jul 3, 2026 00:59 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionCommon Stock | 40,000 | $1.00 | $40,000.00 |
DisclosureSEC source: 0001437749-26-022662 · rdgdoc.xml · nonDerivative · entry 1 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 29, 2026 Filed Jul 3, 2026 00:59 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to purchase common stock · Derivative | 30,000 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0001437749-26-022662 · rdgdoc.xml · derivative · entry 4 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2036-06-29 F3 · derivative.exercise_date: The options fully vest as of June 30, 2027. Read SEC document |
| December 31, 2025 Filed Dec 22, 2025 16:53 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionOption to purchase common stock · Derivative | 68,750 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-25-038506 · rdgdoc.xml · derivative · entry 3 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,750 shares Expires 2025-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2025 Filed Dec 22, 2025 16:53 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Tax withholdingCommon Stock | 13,750 | $2.00 | $27,500.00 |
DisclosureSEC source: 0001437749-25-038506 · rdgdoc.xml · nonDerivative · entry 2 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,654 F1 · kind: Represents a net exercise of outstanding stock options. The reporting person received 55,000 shares of common stock on the net exercise of option to purchase 68,750 shares of common stock. The issuer withheld 13,750 shares of common stock underlying the option for payment of the exercise price using the closing price of $2.00. Read SEC document |
| December 17, 2025 Filed Dec 22, 2025 16:53 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionCommon Stock | 68,750 | $0.40 | $27,500.00 |
DisclosureSEC source: 0001437749-25-038506 · rdgdoc.xml · nonDerivative · entry 1 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 13:36 UTC Amendment | Nuo Therapeutics, Inc. AURX · Entity 7149 | Tax withholdingCommon Stock | 27,659 | $1.74 | $48,126.66 |
DisclosureSEC source: 0001437749-25-024508 · rdgdoc.xml · nonDerivative · entry 2 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,654 F1 · kind: Represents a net exercise of outstanding stock options. The reporting person received 92,654 shares of common stock on the net exercise of option to purchase 120,313 shares of common stock. The issuer withheld 27,659 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 13:36 UTC Amendment | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionCommon Stock | 120,313 | $0.40 | $48,125.20 |
DisclosureSEC source: 0001437749-25-024508 · rdgdoc.xml · nonDerivative · entry 1 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 13:26 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Tax withholdingCommon Stock | 27,659 | $1.74 | $48,126.66 |
DisclosureSEC source: 0001437749-25-024505 · rdgdoc.xml · nonDerivative · entry 2 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,654 F1 · kind: Represents a net exercise of outstanding stock options. The reporting person received 90,606 shares of common stock on the net exercise of option to purchase 120,313 shares of common stock. The issuer withheld 27,659 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 13:26 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionCommon Stock | 120,313 | $0.40 | $48,125.20 |
DisclosureSEC source: 0001437749-25-024505 · rdgdoc.xml · nonDerivative · entry 1 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2024 Filed Jul 22, 2024 22:58 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to Purchase Common Stock · Derivative | 40,000 | $0.33 Strike: $0.33 | $13,200.00 |
DisclosureSEC source: 0001437749-24-023228 · rdgdoc.xml · derivative · entry 1 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2034-07-17 F1 · derivative.exercise_date: Options fully vest on one year anniversary of grant. Read SEC document |
| March 04, 2022 Filed Apr 27, 2022 01:34 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to Purchase Common Stock · Derivative | 75,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001437749-22-009789 · rdgdoc.xml · derivative · entry 2 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-03-04 Read SEC document |
| March 04, 2022 Filed Apr 27, 2022 01:34 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to Purchase Common Stock · Derivative | 36,666 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001437749-22-009789 · rdgdoc.xml · derivative · entry 1 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,666 Underlying: Common Stock · 36,666 shares Expires 2032-03-04 F1 · date: Granted in settlement of compensation liability for period January 1, 2019 through April 30, 2019 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 16:29 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to Purchase Common Stock · Derivative | 68,750 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001091596-19-000001 · primary_doc.xml · derivative · entry 1 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,750 Underlying: COMMON STOCK · 68,750 shares Expires 2015-12-31 Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 19:53 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | GrantOption to Purchase Common Stock · Derivative | 120,313 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001605411-18-000002 · primary_doc.xml · derivative · entry 1 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,313 Underlying: COMMON STOCK · 120,313 shares Expires 2025-08-09 Read SEC document |
| August 09, 2018 Filed Aug 4, 2025 13:36 UTC Amendment | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionOption to purchase common stock · Derivative | 120,313 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-25-024508 · rdgdoc.xml · derivative · entry 3 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,313 shares Expires 2025-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2018 Filed Aug 4, 2025 13:26 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | Exercise / conversionOption to purchase common stock · Derivative | 120,313 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-25-024505 · rdgdoc.xml · derivative · entry 3 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,313 shares Expires 2025-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 01:17 UTC | Nuo Therapeutics, Inc. NONE · Entity 7149 | GrantOption to purchase Common Stock · Derivative | 40,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001144204-17-001878 · v456634_4.xml · derivative · entry 1 WINZER C ERIC · CIK 0001205362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2026-07-01 F1 · date: The grant of these options was approved by the issuer's board of directors on July 1, 2016, subject to stockholder approval of the 2016 Omnibus Incentive Compensation Plan under which the options were granted. Stockholder approval was obtained by means of a written consent and the issuer filed a related Information Statement on Schedule 14C with the SEC on November 25, 2016. The stockholder approval became effective on January 9, 2017. F2 · derivative.exercise_date: Of these options, 15,000 vested immediately, and 25,000 vested on 1/1/17. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.